Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
Giorgio Trinchieri(National Cancer Institute), D Santoli(The Wistar Institute)
Cited by 736
Related Papers
Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice
|The Journal of Immunology|1997|175
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
|Journal of Clinical Investigation|2013|166
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
|Clinical Cancer Research|2011|109
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
|The Journal of Immunology|2009|99
Melanoma and microbiota: Current understanding and future directions
|Cancer Cell|2023|78